Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century?
Esselstyn
Caldwell B
CB
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000266:history / Q000601:surgery; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000178:diet therapy / Q000188:drug therapy / Q000266:history / Q000628:therapy*; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015409:Mastectomy, Radical / Q000266:history; D019365:Metaphor; D012307:Risk Factors; D015607:Stents; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors